Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 56,801 shares at $62.56 ($3.5M) on 2021-02-10, disclosed to the SEC on 2021-02-10.
Open-market sale of $3.5M ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.40 | 7,314 | $449K | 12.7% |
| 2 | $61.40 | 7,314 | $449K | 12.7% |
| 3 | $62.20 | 2,686 | $167K | 4.7% |
| 4 | $62.20 | 2,686 | $167K | 4.7% |
| 5 | $62.07 | 5,840 | $362K | 10.3% |
| 6 | $62.07 | 5,840 |
| $362K |
| 10.3% |
| 7 | $63.23 | 4,160 | $263K | 7.4% |
| 8 | $63.23 | 4,160 | $263K | 7.4% |
| 9 | $61.51 | 795 | $49K | 1.4% |
| 10 | $62.56 | 6,801 | $425K | 12.0% |
| 11 | $62.56 | 6,801 | $425K | 12.0% |
| 12 | $63.25 | 1,204 | $76K | 2.2% |
| 13 | $64.27 | 1,200 | $77K | 2.2% |
| Total | $62.26 avg | 56,801 | $3.5M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |